Raymond James Financial Services Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $409M | Sell |
3,603,148
-30,866
| -0.8% | -$3.67M | 0.55% | 33 |
|
|
2024
Q2 | $450M | Buy |
3,634,014
+59,142
| +2% | +$7.62M | 0.64% | 25 |
|
|
2024
Q1 | $472M | Buy |
3,574,872
+22,933
| +0.6% | +$2.83M | 0.7% | 22 |
|
|
2023
Q4 | $387M | Buy |
3,551,939
+90,643
| +3% | +$9.41M | 0.63% | 30 |
|
|
2023
Q3 | $356M | Buy |
3,461,296
+85,411
| +3% | +$9.21M | 0.65% | 28 |
|
|
2023
Q2 | $390M | Buy |
3,375,885
+38,435
| +1% | +$4.36M | 0.69% | 24 |
|
|
2023
Q1 | $355M | Buy |
3,337,450
+26,643
| +0.8% | +$2.88M | 0.67% | 25 |
|
|
2022
Q4 | $367M | Sell |
3,310,807
-41,441
| -1% | -$4.24M | 0.74% | 20 |
|
|
2022
Q3 | $289M | Buy |
3,352,248
+1,718
| +0.1% | +$153K | 0.64% | 27 |
|
|
2022
Q2 | $305M | Buy |
3,350,530
+138,188
| +4% | +$12.3M | 0.66% | 25 |
|
|
2022
Q1 | $264M | Buy |
3,212,342
+148,796
| +5% | +$11.7M | 0.5% | 38 |
|
|
2021
Q4 | $235M | Buy |
3,063,546
+113,361
| +4% | +$9.03M | 0.44% | 41 |
|
|
2021
Q3 | $222M | Buy |
2,950,185
+101,212
| +4% | +$7.7M | 0.45% | 42 |
|
|
2021
Q2 | $222M | Buy |
2,848,973
+44,360
| +2% | +$3.3M | 0.45% | 42 |
|
|
2021
Q1 | $206M | Buy |
2,804,613
+62,282
| +2% | +$4.59M | 0.47% | 41 |
|
|
2020
Q4 | $214M | Buy |
2,742,331
+145,595
| +6% | +$11.1M | 0.53% | 29 |
|
|
2020
Q3 | $206M | Buy |
2,596,736
+83,198
| +3% | +$6.52M | 0.59% | 27 |
|
|
2020
Q2 | $185M | Buy |
2,513,538
+175,317
| +7% | +$13.2M | 0.59% | 26 |
|
|
2020
Q1 | $172M | Sell |
2,338,221
-99,892
| -4% | -$7.85M | 0.75% | 20 |
|
|
2019
Q4 | $212M | Buy |
2,438,113
+187,290
| +8% | +$15.4M | 0.68% | 23 |
|
|
2019
Q3 | $181M | Buy |
2,250,823
+151,357
| +7% | +$12.1M | 0.66% | 24 |
|
|
2019
Q2 | $168M | Buy |
2,099,466
+91,199
| +5% | +$6.98M | 0.64% | 26 |
|
|
2019
Q1 | $159M | Buy |
2,008,267
+169,137
| +9% | +$12.7M | 0.66% | 24 |
|
|
2018
Q4 | $134M | Buy |
1,839,130
+205,852
| +13% | +$14.5M | 0.71% | 24 |
|
|
2018
Q3 | $111M | Buy |
1,633,278
+126,456
| +8% | +$8.06M | 0.5% | 31 |
|
|
2018
Q2 | $87.3M | Buy |
1,506,822
+199,457
| +15% | +$11.3M | 0.44% | 35 |
|
|
2018
Q1 | $68M | Buy |
1,307,365
+154,589
| +13% | +$8.35M | 0.39% | 44 |
|
|
2017
Q4 | $61.9M | Sell |
1,152,776
-9,724
| -0.8% | -$539K | 0.39% | 41 |
|
|
2017
Q3 | $71M | Buy |
1,162,500
+32,347
| +3% | +$1.96M | 0.45% | 38 |
|
|
2017
Q2 | $69.1M | Buy |
1,130,153
+137,007
| +14% | +$8.34M | 0.48% | 34 |
|
|
2017
Q1 | $60.2M | Buy |
993,146
+114,724
| +13% | +$6.96M | 0.46% | 37 |
|
|
2016
Q4 | $49.3M | Buy |
878,422
+371,090
| +73% | +$21.7M | 0.41% | 40 |
|
|
2016
Q3 | $30.2M | Sell |
507,332
-54,374
| -10% | -$3.18M | 0.27% | 81 |
|
|
2016
Q2 | $30.9M | Buy |
561,706
+71,603
| +15% | +$3.81M | 0.3% | 68 |
|
|
2016
Q1 | $24.7M | Buy |
490,103
+34,039
| +7% | +$1.67M | 0.28% | 77 |
|
|
2015
Q4 | $23M | Buy |
456,064
+69,998
| +18% | +$3.53M | 0.27% | 88 |
|
|
2015
Q3 | $18.2M | Buy |
386,066
+287,705
| +292% | +$15.3M | 0.3% | 74 |
|
|
2015
Q2 | $5.34M | Buy |
98,361
+20,823
| +27% | +$1.17M | 0.38% | 62 |
|
|
2015
Q1 | $4.25M | Buy |
77,538
+1,675
| +2% | +$94.8K | 0.21% | 126 |
|
|
2014
Q4 | $4.11M | Buy |
75,863
+2,096
| +3% | +$117K | 0.21% | 124 |
|
|
2014
Q3 | $4.17M | Buy |
+73,767
| New | +$4.14M | 0.23% | 114 |
|
|
2014
Q2 | – | Sell |
-76,066
| Closed | -$4.12M | – | 524 |
|
|
2014
Q1 | $4.12M | Buy |
76,066
+800
| +1% | +$41.4K | 0.24% | 103 |
|
|
2013
Q4 | $3.6M | Buy |
75,266
+1,921
| +3% | +$87.8K | 0.22% | 126 |
|
|
2013
Q3 | $3.33M | Sell |
73,345
-244,355
| -77% | -$11.2M | 0.22% | 124 |
|
|
2013
Q2 | $14.1M | Buy |
+317,700
| New | +$14.2M | 0.41% | 49 |
|
Other funds holding MRK
Raymond James Financial Services Advisors's MRK Position: Q3 2024 in Review
Raymond James Financial Services Advisors reduced its Merck (MRK) stake by 0.85% in Q3 2024, selling an estimated $3.67M and leaving 3,603,148 shares worth $409M. The position accounts for 0.55% of the portfolio, ranked #33.
Raymond James Financial Services Advisors first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $472M in Q1 2024. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- Raymond James Financial Services Advisors held 3,603,148 shares of Merck worth $409M as of Q3 2024.
- Raymond James Financial Services Advisors sold 30,866 Merck shares in Q3 2024, an estimated $3.67M.
- Merck made up 0.55% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #33 holding.
- Raymond James Financial Services Advisors first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
- Raymond James Financial Services Advisors's Merck position peaked at $472M in Q1 2024.
- 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.